Cargando…
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
SIMPLE SUMMARY: In recent years, there have been several advances in the care of advanced bladder cancer, highlighted by the addition of immune checkpoint inhibitors to the care of advanced disease. Despite these advances, there is a need for further improvement; the morbidity and mortality associat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997162/ https://www.ncbi.nlm.nih.gov/pubmed/35406567 http://dx.doi.org/10.3390/cancers14071795 |